HAL (France)open access
Extrahepatic Gene Editing In Vivo Using Organic Solvent‐Free Lipid Nanoparticles
PEG alternative, Extrahepatic delivery, 0, CRISPR‐Cas9, Human primary cells, 1, Gene delivery, Organic solvent‐free lipid nanoparticles
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 213176
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.